MAY 23, 2017 10:57 AM PDT

New Approach to Treating Autoimmune Disease: "PPCA"

WRITTEN BY: Kara Marker

To treat autoimmune diseases like multiple sclerosis (MS) and hemophagocytic lymphohistiocytosis (HLH), it’s important to sacrifice as few healthy immune cells as possible. While the autoimmune reaction is indeed damaging to the body, the immune system is still needed for protection against regular exposure to agents like viruses and bacteria. A new approach seems to find the right balance, from scientists at Cincinnati Children's Hospital Medical Center.

Activated mouse T-cells with markers indicating DNA damage repair signaling (shown in pink). Credit: Cincinnati Children's

In mouse models of both MS and HLH, researchers saw that genomic stress results in DNA damage in rapidly expanding T cells. "Because T cells are always in a race with different viruses and bacteria, they have learned how to adapt and divide rapidly to respond, but this stress on their DNA means they also are living right on the edge of death," described lead author Michael B. Jordan, MD.

Jordan’s study involved inhibiting the normal process of DNA damage repair in MS and HLH mouse model cells. They used nutlin molecules to alter p53 activity, a protein responsible for regulating DNA damage repair. Additionally, CHK1/2 and WEE1 cell cycle checkpoint proteins were inhibited. “We threw them off balance and into a chasm of death,” Jordan explained

After manipulating the cells to inhibit DNA repair, researchers applied their new treatment approach, “p53 potentiation with checkpoint abrogation,” or PPCA. Abrogation describes a method of treating cancer where cell cycle checkpoints are inhibited.

In HLH mouse models, researchers saw PPCA reducing disease and improving long-term survival. In mouse models of MS, the treatment eliminated “aggressively expanding” T cells and “either reversed or prevented paralysis. While the present findings are promising, the study researchers stress that much research still needed to illustrate how PPCA could one day be applied to human cases of immune diseases like MS and HLH.

About MS

MS is characterized by an autoimmune attack on the central nervous system, specifically the protective layer of myelin sheath that coats and insulates nerves. Because of this attack, MS results in muscle weakness, numbness, or loss of coordination.

About HLH

HLH is a disease caused by too many activated immune cells, either an acquired condition through viral or bacterial infections or an inherited condition through genetic mutations.

HLH can cause a variety of symptoms, including fever, enlarged liver or spleen, cytopenia, and neurological abnormalities. Treatment options vary depending on the source of disease: antibiotics and antivirals are used to treat the infections that triggered HLH and allogeneic hematopoietic cell transplantation, chemotherapy, and immunotherapy are options to replace or destroy excess immune cells in cases of inherited HLH.

The present study was published in the journal PNAS Early Edition.

Sources: PubMed Health, National Center for Advancing Translational Sciences, Cincinnati Children's Hospital Medical Center

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 17, 2019
Immunology
SEP 17, 2019
Zika Vaccine Shows to Be Potentially Safer
University of Nebraska-Lincoln researchers may have identified a vaccine that would defend against Zika virus without producing antibodies....
SEP 17, 2019
Immunology
SEP 17, 2019
Mapping Brain Immunity
Scientists succeeded in demonstrating for the first time that the phagocytes in the brain, the so-called microglia, all have the same core signature...
SEP 17, 2019
Health & Medicine
SEP 17, 2019
Toxic Air is Shortening Children's Lifespans
According to the State of Global Air 2019 report, air pollution is currently shortening life expectancy by an average of 20 months worldwide. This means th...
SEP 17, 2019
Immunology
SEP 17, 2019
The Morel of the Story
It’s morel mushroom season in the United States and it promises to be a good one! Plenty of rain and warmth favor the growth of this delicatessen, bu...
SEP 17, 2019
Immunology
SEP 17, 2019
The C-word. Michael Kinch's new book and the future of Cancer Treatment
The C-word. Dare we say it? Is a cure for cancer within reach?   Professor Michael Kinch https://publichealth.wustl.edu/scholars/michael-s-kinch/ of W...
SEP 17, 2019
Genetics & Genomics
SEP 17, 2019
Smoking Dads Alter Immune Gene Epigenetics & Increase Risk of Asthma in Kids
Using a group of 1,629 couples, scientists in Taiwan have analyzed the impact of paternal smoking on children....
Loading Comments...